S07-2005 racemic is a potent and selectivealdo-keto reductase 1C3 (AKR1C3)inhibitor with anIC₅₀value of 0.13 μM and 0.75 μM for AKR1C3 and AKR1C4, respectively. S07-2005 racemic has potential as a chemotherapeutic potentiator forcancer drug resistance^[1].

IC₅₀: 2.88 ± 1.10 μM (AKR1C1), 0.13 ± 0.03 μM (AKR1C3), 0.75 ± 0.32 μM (AKR1C4)^[1]

373.40

C₂₀H₂₃NO₆

1826337-40-9

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.